MedPath

Effect of pentoxifylline on restless leg syndrome

Early Phase 1
Recruiting
Conditions
Restless Leg Syndrome.
Restless legs syndrome
G25.81
Registration Number
IRCT20180219038797N1
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

All the patients undergoing hemodialysis that have Informed consent

Exclusion Criteria

Patient dissatisfaction
Death

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain and comfort of legs. Timepoint: At the end of each month for 3 months. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath